{
  "abstract": "In hepatitis B virus (HBV) infection, the capacity to mount a functional virus-specific T-cell response has long been considered the principal, if not the sole, immunological determinant of viral control.1 However, accumulating clinical evidence increasingly points to a central role for HBV-specific B cells, not only in preventing infection but also in shaping the outcome of therapeutic interventions.",
  "authors": [
    {
      "affiliations": [
        "Duke-NUS Medical School, Singapore"
      ],
      "name": "Antonio Bertoletti"
    },
    {
      "affiliations": [
        "Duke-NUS Medical School, Singapore"
      ],
      "name": "Shubhankar Sunil Ambike"
    }
  ],
  "title": "Recovery of HBV-specific B cell function after discontinuation of nucleos(t)ide analogue therapy: new insight and future challenges",
  "uid": "0a5a0f84-4ced-592e-80b9-a7e87081d41b"
}